Pelvic MRI at 3.0 Tesla

Journal de Radiologie

Volumn 90, Issue 3 C1, 2009, Pages 277-286

  Leautaud A ^a   Marcus, C ^a   Ben Salem, D ^b   Bouche O ^a   Graesslin, O ^c   Hoeffel, C ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

High field MRI; Magnetic resonance spectroscopy; Pelvis

Indexed keywords

ARTIFACT REDUCTION; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIELECTRIC CONSTANT; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PELVIS; PROSTATE; PROTON NUCLEAR MAGNETIC RESONANCE; RECTUM; REVIEW; ADENOCARCINOMA; ADULT; AGED; ANUS TUMOR; ARTIFACT; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL STROMAL TUMOR; HUMAN; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE TUMOR; RECTUM FISTULA; RECTUM TUMOR; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; ANUS NEOPLASMS; ARTIFACTS; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; GENITAL NEOPLASMS, FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATIC NEOPLASMS; RECTAL FISTULA; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 65349175316     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(09)72506-5     Document Type: Review

References (43)

1. Cornfeld DM, Weinreb JC. MR imaging of the prostate : 1,5T versus 3T. Magn Reson Imaging Clin N Am 2007;15:433-48.
2. Winter L, Bruhn H, Langrehr J, Neu-haus P, Felix R, Hänninen LE. Magnetic resonance imaging in suspected rectal cancer: determining tumor localization, stage, and sphincter-saving resectability at 3-Tesla-sustained high resolution. Ac- ta Radiol 2007;48:379-87.
3. Chun HK, Choi D, Kim MJ, et al. Preoperative staging of rectal cancer: comparison of 3-T high-field MRI and endorectal sonography. AJR Am J Roentgenol 2006;187:1557-62.
4. Kim CK, Park BK, Lee HM, Kwon GY. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol 2007;42:842-7.
5. Kim CK, Kim SH, Chun HK, et al. Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol 2006;16:972-80.
6. Torricelli P, Ferraresi S, Fiocchi F, et al. 3-T MRI in the preoperative evaluation of depth of myometrial infiltration in endometrial cancer. AJR Am J Roentgenol 2008;190:489-95.
7. Kuhl CK, Traber F, Schild HH. Whole-body high-field-strength (3.0-T) MR Imaging in Clinical Practice. Part I. Technical considerations and clinical applications. Radiology 2008;246:675-96.
8. Hoult DI, Phil D. Sensitivity and power deposition in a high-field imaging experiment. J Magn Reson Imaging 2000; 12:46-67.
9. Wen H, Denison TJ, Singerman RW, Balaban RS. The intrinsic signal-to-noise ratio in human cardiac imaging at 1.5, 3, and 4T. J Magn Reson 1997;125:65-71.
10. Frayne R, Goodyear BG, Dickhoff P, Lauzon ML, Sevick RJ. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 2003;38:385-402.
11. Hussain SM, Wielopolski PA, Martin DR. Abdominal magnetic resonance imaging at 3.0 T: problems or a promise for the future? Top Magn Reson Imaging 2005; 16:325-35.
12. Merkle EM, Dale BM. Abdominal MRI at 3.0 T: the basics revisited. AJR Am J Roentgenol 2006;186:1524-32.
13. Akisik FM, Sandrasegaran K, Aisen AM, Lin C, Lall C. Abdominal MR imaging at 3.0 T Radiographics 2007;27:1433-44.
14. Collins CM, Liu W, Schreiber W, Yang QX, Smith MB. Central brightening due to constructive interference with, without, and despite dielectric resonance. J Magn Reson Imaging 2005;21:192-6.
15. von Falkenhausen MM, Lutterbey G, Morrakkabati-Spitz N, et al. High-field-strength MR imaging of the liver a 3.0 T: intraindividual comparative study with MR imaging at 1.5T. Radiology 2006; 241:156-66.
16. Forbes KP, Pipe JG, Bird CR, Heiserman JE. PROPELLER MRI: clinical testing of a novel technique for quantification and compensation of head motion. J Ma-gn Reson Imaging 2001;14:215-22.
17. Graf H, Lauer UA, Schick F. Eddy-current induction in extended metallic parts as a source of considerable torsional moment. J Magn Reson Imaging 2006; 23:585-90.
18. Fütterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer: local staging at 3-T endorectal MR imaging-early experience. Radiology 2006;238:184-91.
19. Kim DH, Margolis D, Xing L, Daniel B, Spielman D. In vivo prostate magnetic resonance spectroscopic imaging using two-dimensional J-resolved PRESS at 3 T. Magn Reson Med 2005;53:1117-82.
20. Morakkabati-Spitz N, Gieseke J, Kuhl C, et al. 3.0-T high-field magnetic resonance imaging of the female pelvis: preliminary experiences. Eur radiol 2005;15:639-44.
21. Morakkabati-Spitz N, Gieseke J, Kuhl C, et al. MRI of the pelvis at 3 T: very high spatial resolution with sensitivity encoding and flip-angle sweep technique in clinically acceptable scan time. Eur Radiol 2006;16:634-41.
22. Ethofer T, Mader I, Seeger U, et al. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med 2003;50:1296-301.
23. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230:652-9.
24. Ikonen S, Kivisaari L, Tervahartiala P, Vehmas T, Taari K, Rannikko S. Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 2001;42:348-54.
25. Ikonen S, Karkkainen P, Kivisaari L, et al. Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2 weighted fast spin echo and three-dimensional dual-echo, steady-state sequences. Eur Radiol 2001;11:236-41.
26. Presti JC Jr, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol 1996;166:103-8.
27. Cornud F, Flam T, Chauveinc L, et al. Extraprostatic spread of clinically localized prostate cancer : factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 2002;224:203-10.
28. Rouviere O, Hartman RP, Lyonnet D. Prostate MR imaging at high-field strength: evolution or revolution? Eur Radiol 2006;16:276-84.
29. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006;241:449-58.
30. Trabesinger AH, Meier D, Dydak U, La-merichs R, Boesiger P. Optimizing PRESS localized citrate detection at 3 Tesla. Magn Reson Med 2005;54:51-8.
31. Kim CK, Park BK, Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J Comput Assist To-mogr 2006;30:7-11.
32. Gibbs P, Pickles MD, Turnbull LW. Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol 2006;41:185-8.
33. Pickles MD, Gibbs P, Sreenivas M, Turnbull LW. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging 2006; 23:130-4.
34. Kim CK, Park BK, Han JJ, Kang TW, Lee HM. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J Comput Assist Tomogr 2007; 31:656.
35. Costouros NG, Coakley FV, Westphalen AC, et al. Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2007;188:812-6.
36. Amsellem-Ouazana D, Younes P, Conquy S, et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005;47:582-6.
37. Bipat S, Glas AS, van der Velden J, Zwin-derman AH, Bossuyt PM, Stoker J. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 2003;91:59-66.
38. Morakkabati-Spitz N, Schild HH, Kuhl CK, et al. Female pelvis: MR imaging at 3.0T with sensitivity encoding and flip-angle sweep technique. Radiology 2006; 241:538-45.
39. Hoeffel C, Marra MD, Azizi L, et al. Bilan pré-opératoire des cancers du rectum en IRM pelvienne haute résolution avec antenne en réseau phasé. J Radiol 2006; 87:1821-30.
40. Rousset P, Hoeffel C. Tumeurs du rectum: aspects IRM et scanner. J Radiol 2007;88:1679-87.
41. Zhang XM, Zhang HL, Yu Y, et al. 3-T MRI of rectal carcinoma : preoperative diagnosis, staging, and planning of sphincter-sparing surgery. AJR Am J Roentgenol 2008;190:1271-8.
42. Kim CK, Kim SH, Choi D, et al. Comparison between 3-T magnetic resonance imaging and multi-detector row computed tomography for the preoperative evaluation of rectal cancer. J Comput Assist Tomogr 2007;31: 853-9.
43. Futterer JJ, Yakar D, Strijk SP, Barentsz JO. Preoperative 3T MR imaging of rectal cancer: local accuracy using a two-dimensional and three-dimensional T2- weighted turbo spin echo sequence. Eur J Radiol 2008;65:66-71.